Ranveer Vasdev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ranveer Vasdev has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Christopher J. Weight
Department of Urology, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH 44195, USA
3 shared publications - Jack Rickman
Department of Urology, University of Minnesota, Minneapolis, MN, United States
3 shared publications - Nicholas Heller
Department of Urology Cleveland Clinic Cleveland OH USA
3 shared publications - Resha Tejpaul
Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota, USA
3 shared publications - Sean McSweeney
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
3 shared publications - Abhinav Khanna
Department of Urology, Mayo Clinic, Rochester, MN
2 shared publications
Latest Publications
- 17 February 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (3) , 482.e1-482.e6
Intradetrusor botox injection and augmentation cystoplasty trends among spina bifida patients at US freestanding children's hospitals
- 17 February 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (3) , 482.e1-482.e6
Intradetrusor botox injection and augmentation cystoplasty trends among spina bifida patients at US freestanding children's hospitals
- 15 September 2023
- Published by Elsevier in Urologic Clinics of North America
- Vol. 51 (1) , 91-103
Artificial Intelligence in Pediatric Urology
- 15 September 2023
- Published by Elsevier in Urologic Clinics of North America
- Vol. 51 (1) , 91-103
Artificial Intelligence in Pediatric Urology
- Open Access
- 27 March 2023
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 1 (2)
Criteria adherence and citation impact of urologic Cochrane review co‐publications
Introduction: Cochrane systematic reviews are widely recognized as authoritative sources of evidence. To improve dissemination and impact, editorial groups often encourage co‐publication of their reviews in other journals. Our study aimed to analyze urology‐relevant co‐publications and determine their adherence to Cochrane's four co‐publication criteria and impact using citation analysisMethods: We systematically identified all Cochrane reviews published by the Urology, Incontinence, Renal, and Transplantation Groups from 1998 to 2021 as well as subsequent co‐publications using MEDLINE, Web of Science, Scopus, and Google Scholar databases. We also determined adherence to Cochrane's four co‐publication criteria and analyzed citation rates.Results: Of the 202 Cochrane reviews included, 52 (25.7%) had an associated co‐publication. The majority of the co‐publications corresponded to the Urology Group (39; 76.9%), followed by the Incontinence (9; 17.3%) and Kidney and Transplant Group (3; 5.8%). Only 21 (40.0%) co‐publications met all four co‐publication criteria, with the most common criteria not satisfied was inclusion of the word “Cochrane” in the co‐publication title (50% adherence). The proportion adhering to a subset of criteria significantly increased for reviews published between 2013 and 2021 compared to those from 1998 to 2012. Compared to corresponding Cochrane reviews, there was no significant difference in the number of citations of co‐publications across all sampled databases, although co‐publication citations were usually less than those of original reviews.Conclusion: Approximately one in four urology‐related Cochrane reviews are co‐published. Though co‐publications garnered a considerable number of citations that could help in the dissemination of Cochrane reviews, many are not readily identifiable as such.
- 27 March 2023
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 1 (2)
Open AccessCriteria adherence and citation impact of urologic Cochrane review co‐publications
Introduction: Cochrane systematic reviews are widely recognized as authoritative sources of evidence. To improve dissemination and impact, editorial groups often encourage co‐publication of their reviews in other journals. Our study aimed to analyze urology‐relevant co‐publications and determine their adherence to Cochrane's four co‐publication criteria and impact using citation analysisMethods: We systematically identified all Cochrane reviews published by the Urology, Incontinence, Renal, and Transplantation Groups from 1998 to 2021 as well as subsequent co‐publications using MEDLINE, Web of Science, Scopus, and Google Scholar databases. We also determined adherence to Cochrane's four co‐publication criteria and analyzed citation rates.Results: Of the 202 Cochrane reviews included, 52 (25.7%) had an associated co‐publication. The majority of the co‐publications corresponded to the Urology Group (39; 76.9%), followed by the Incontinence (9; 17.3%) and Kidney and Transplant Group (3; 5.8%). Only 21 (40.0%) co‐publications met all four co‐publication criteria, with the most common criteria not satisfied was inclusion of the word “Cochrane” in the co‐publication title (50% adherence). The proportion adhering to a subset of criteria significantly increased for reviews published between 2013 and 2021 compared to those from 1998 to 2012. Compared to corresponding Cochrane reviews, there was no significant difference in the number of citations of co‐publications across all sampled databases, although co‐publication citations were usually less than those of original reviews.Conclusion: Approximately one in four urology‐related Cochrane reviews are co‐published. Though co‐publications garnered a considerable number of citations that could help in the dissemination of Cochrane reviews, many are not readily identifiable as such.
- Open Access
- 30 September 2022
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 26 (3) , 227-233
Data Gap in Sacral Neuromodulation Documentation: Call to Improve Documentation Protocols
Purpose: We quantified patient record documentation of sacral neuromodulation (SNM) threshold testing and programming parameters at our institution to identify opportunities to improve therapy outcomes and future SNM technologies.Methods: A retrospective review was conducted using 127 records from 40 SNM patients. Records were screened for SNM documentation including qualitative and quantitative data. The qualitative covered indirect references to threshold testing and the quantitative included efficacy descriptions and device programming used by the patient. Findings were categorized by visit type: percutaneous nerve evaluation (PNE), stage 1 (S1), permanent lead implantation, stage 2 (S2) permanent impulse generator implantation, device-related follow-up, or surgical removal.Results: Documentation of threshold testing was more complete during initial implant visits (PNE and S1), less complete for S2 visits, and infrequent for follow-up clinical visits. Surgical motor thresholds were most often referred to using only qualitative comments such as “good response” (88%, 100% for PNE, S1) and less commonly included quantitative values (68%, 84%), locations of response (84%, 83%) or specific contacts used for testing (0%). S2 motor thresholds were less well documented with qualitative, quantitative, and anatomical location outcomes at 70%, 48%, and 36% respectively. Surgical notes did not include specific stimulation parameters or contacts used for tests. Postoperative sensory tests were often only qualitative (80%, 67% for PNE, S1) with quantitative values documented much less frequently (39%, 9%) and typically lacked sensory locations or electrode-specific results. For follow-up visits, <10% included quantitative sensory test outcomes. Few records (<7%) included device program settings recommended for therapy delivery and none included therapy-use logs.Conclusions: While evidence suggests contact and parameter-specific programming can improve SNM therapy outcomes, there is a major gap in the documentation of this data. More detailed testing and documentation could improve therapeutic options for parameter titration and provide design inputs for future technologies.
- 30 September 2022
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 26 (3) , 227-233
Open AccessData Gap in Sacral Neuromodulation Documentation: Call to Improve Documentation Protocols
Purpose: We quantified patient record documentation of sacral neuromodulation (SNM) threshold testing and programming parameters at our institution to identify opportunities to improve therapy outcomes and future SNM technologies.Methods: A retrospective review was conducted using 127 records from 40 SNM patients. Records were screened for SNM documentation including qualitative and quantitative data. The qualitative covered indirect references to threshold testing and the quantitative included efficacy descriptions and device programming used by the patient. Findings were categorized by visit type: percutaneous nerve evaluation (PNE), stage 1 (S1), permanent lead implantation, stage 2 (S2) permanent impulse generator implantation, device-related follow-up, or surgical removal.Results: Documentation of threshold testing was more complete during initial implant visits (PNE and S1), less complete for S2 visits, and infrequent for follow-up clinical visits. Surgical motor thresholds were most often referred to using only qualitative comments such as “good response” (88%, 100% for PNE, S1) and less commonly included quantitative values (68%, 84%), locations of response (84%, 83%) or specific contacts used for testing (0%). S2 motor thresholds were less well documented with qualitative, quantitative, and anatomical location outcomes at 70%, 48%, and 36% respectively. Surgical notes did not include specific stimulation parameters or contacts used for tests. Postoperative sensory tests were often only qualitative (80%, 67% for PNE, S1) with quantitative values documented much less frequently (39%, 9%) and typically lacked sensory locations or electrode-specific results. For follow-up visits, <10% included quantitative sensory test outcomes. Few records (<7%) included device program settings recommended for therapy delivery and none included therapy-use logs.Conclusions: While evidence suggests contact and parameter-specific programming can improve SNM therapy outcomes, there is a major gap in the documentation of this data. More detailed testing and documentation could improve therapeutic options for parameter titration and provide design inputs for future technologies.
- Open Access
- 4 January 2022
- Published by Frontiers Media SA in Frontiers in Digital Health
- Vol. 3, 797607
Automatic Segmentation of Kidneys and Kidney Tumors: The KiTS19 International Challenge
Purpose: Clinicians rely on imaging features to calculate complexity of renal masses based on validated scoring systems. These scoring methods are labor-intensive and are subjected to interobserver variability. Artificial intelligence has been increasingly utilized by the medical community to solve such issues. However, developing reliable algorithms is usually time-consuming and costly. We created an international community-driven competition (KiTS19) to develop and identify the best system for automatic segmentation of kidneys and kidney tumors in contrast CT and report the results.Methods: A training and test set of CT scans that was manually annotated by trained individuals were generated from consecutive patients undergoing renal surgery for whom demographic, clinical and outcome data were available. The KiTS19 Challenge was a machine learning competition hosted on grand-challenge.org in conjunction with an international conference. Teams were given 3 months to develop their algorithm using a full-annotated training set of images and an unannotated test set was released for 2 weeks from which average Sørensen-Dice coefficient between kidney and tumor regions were calculated across all 90 test cases.Results: There were 100 valid submissions that were based on deep neural networks but there were differences in pre-processing strategies, architectural details, and training procedures. The winning team scored a 0.974 kidney Dice and a 0.851 tumor Dice resulting in 0.912 composite score. Automatic segmentation of the kidney by the participating teams performed comparably to expert manual segmentation but was less reliable when segmenting the tumor.Conclusion: Rapid advancement in automated semantic segmentation of kidney lesions is possible with relatively high accuracy when the data is released publicly, and participation is incentivized. We hope that our findings will encourage further research that would enable the potential of adopting AI into the medical field.
- 4 January 2022
- Published by Frontiers Media SA in Frontiers in Digital Health
- Vol. 3, 797607
Open AccessAutomatic Segmentation of Kidneys and Kidney Tumors: The KiTS19 International Challenge
Purpose: Clinicians rely on imaging features to calculate complexity of renal masses based on validated scoring systems. These scoring methods are labor-intensive and are subjected to interobserver variability. Artificial intelligence has been increasingly utilized by the medical community to solve such issues. However, developing reliable algorithms is usually time-consuming and costly. We created an international community-driven competition (KiTS19) to develop and identify the best system for automatic segmentation of kidneys and kidney tumors in contrast CT and report the results.Methods: A training and test set of CT scans that was manually annotated by trained individuals were generated from consecutive patients undergoing renal surgery for whom demographic, clinical and outcome data were available. The KiTS19 Challenge was a machine learning competition hosted on grand-challenge.org in conjunction with an international conference. Teams were given 3 months to develop their algorithm using a full-annotated training set of images and an unannotated test set was released for 2 weeks from which average Sørensen-Dice coefficient between kidney and tumor regions were calculated across all 90 test cases.Results: There were 100 valid submissions that were based on deep neural networks but there were differences in pre-processing strategies, architectural details, and training procedures. The winning team scored a 0.974 kidney Dice and a 0.851 tumor Dice resulting in 0.912 composite score. Automatic segmentation of the kidney by the participating teams performed comparably to expert manual segmentation but was less reliable when segmenting the tumor.Conclusion: Rapid advancement in automated semantic segmentation of kidney lesions is possible with relatively high accuracy when the data is released publicly, and participation is incentivized. We hope that our findings will encourage further research that would enable the potential of adopting AI into the medical field.
- 1 December 2021
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 294, 103743
Adenosine A2a receptors modulate TrkB receptor-dependent respiratory plasticity in neonatal rats
- 1 December 2021
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 294, 103743
Adenosine A2a receptors modulate TrkB receptor-dependent respiratory plasticity in neonatal rats